On October 29, 2021, The Federal Drug Administration authorized the pediatric version of the Pfizer COVID-19 vaccine. It’s meant to prevent children between the ages of 5-11 from contracting the virus.
The FDA authorized the Pfizer vaccine based on the data from independent advisory experts and case studies that showed it is a safe and effective treatment option. Children in the 5-11 age group received an immune response comparable to those in the 16-25 demographic.
Here are the key points parents should know about the Pfizer vaccine for kids.
- The vaccine was found to be over 90% effective at preventing COVID-19 in children in the adolescent age group.
- Over 3,100 children received the vaccine during the safety evaluation period. No serious side effects were detected in the study.
- Ongoing evaluations and research continue to look at the safety of the vaccine and the risk of potential side effects.
The Pfizer Vaccine Is a Two-Dose Primary Series
When kids 5-11 receive the COVID-19 vaccine from Pfizer, it’s done in the same way that adults and teens got it earlier in 2021. It comes in two doses which must be spaced at least three weeks apart.
The dosing for kids 12 and older (including adults) is 30 micrograms. With the pediatric dosing, children receive 10 micrograms.
Kids in the adolescent age group make up more than one-third of the total COVID cases for those under the age of 18. Over 8,000 cases in children between the ages of 5-11 required hospitalization.
The other vaccines are also looking at ways to create child-friendly doses to reduce COVID transmission risk. Options for preschoolers and younger are expected in the coming months. Until then, brands like Apricot Power work to potentially provide the additional immunity support needed to stay healthy.